pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
engasertib
engasertib [INN]
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)
Vaderis Therapeutics AG
0 catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSAProcessa Pharmaceuticals, Inc.
0 catalysts
Phase 2
enobosarm
Obesity
Androgen receptor
VERU INC.
← prev
page 38 of 53
next →
131
Pain89
Neurology1
$VERU
0 catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORICOric Pharmaceuticals, Inc.
0 catalysts
Phase 2
enzomenib tartrate
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Sumitomo Pharma Co Ltd
0 catalysts
Phase 2
epaldeudomide
epaldeudomide [INN]
Systemic Lupus Erythematosus
Kangpu Biopharmaceuticals Ltd
0 catalysts
Phase 2
epeleuton
epeleuton [INN]
Sickle Cell Disease
Afimmune Biopharma Ltd
0 catalysts
Phase 2
epetraborole
epetraborole [INN]
Mycobacterium avium Infections
$ANTXAN2 Therapeutics, Inc.
0 catalysts
Phase 2
epsametostat
epsametostat [INN]
Peripheral T-Cell Lymphomas (PTCL)
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Phase 2
esonadogene imvoparvovec
esonadogene imvoparvovec [INN]
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
Wuhan Neurophth Biological Technology Ltd
0 catalysts
Phase 2
estriol
Atrophic Vaginitis (Vaginal Atrophy/Vulvovaginal Atrophy/Urogenital Atrophy)
Estrogen receptor
VaRi Bioscience GmbH
0 catalysts
Phase 2
etigilimab
Adenocarcinoma Of The Gastroesophageal Junction
T-cell immunoreceptor with Ig and ITIM domains
$MREOMereo BioPharma Group plc
0 catalysts
Phase 2
etivelcabtagene erigedleucel
Follicular Lymphoma
Cellectis SA
0 catalysts
Phase 2
evalstotug
evalstotug [INN]
Melanoma
$BCABBioAtla, Inc.
0 catalysts
Phase 2
evarucabgene autoleucel
Refractory Multiple Myeloma
Nexcella Inc
0 catalysts
Phase 2
exaluren
exaluren [INN]
Alport Syndrome
$ELOXEloxx Pharmaceuticals, Inc.
0 catalysts
Phase 2
exendin-(9-39)
Hyperinsulinemia
Glucagon-like peptide 1 receptor
Children's Hospital of Philadelphia
0 catalysts
Phase 2
exeporfinium chloride
exeporfinium chloride [INN]
Hospital Acquired Methicillin-Resistant Staphylococcus aureus (HA-MRSA) Infec…
AMR Bio Ltd
0 catalysts
Phase 2
ezeprogind
ezeprogind [INN]
Progressive Supranuclear Palsy
AlzProtect SAS
0 catalysts
Phase 2
ezurpimtrostat
ezurpimtrostat [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Genfit SA
0 catalysts
Phase 2
famzeretcel
famzeretcel [INN]
Retinitis Pigmentosa (Retinitis)
jCyte Inc
0 catalysts
Phase 2
farletuzumab ecteribulin
Triple-Negative Breast Cancer (TNBC)
Eisai Co Ltd
0 catalysts
Phase 2
fasudil
BRAVYL (fasudil [INN])
Amyotrophic Lateral Sclerosis
Woolsey Pharmaceuticals Inc
0 catalysts
Phase 2
fenretinide
Dengue Fever
$ILPLFIsland Pharmaceuticals Ltd
0 catalysts
Phase 2
fexapotide triflutate
Prostate Cancer
$NYMXFNYMOX PHARMACEUTICAL CORP
0 catalysts
Phase 2
flixebrutinib
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Telios Pharma Inc
0 catalysts
Phase 2
flucytosine ER + vocimagene amiretrorepvec
flucytosine + vocimagene amiretrorepvec
Glioblastoma Multiforme (GBM)
Denovo Biopharma LLC
0 catalysts
Phase 2
fluocinolone acetonide ER
fluocinolone acetonide
Diabetic Macular Edema
Glucocorticoid receptor
Eclipse Life Sciences Inc
0 catalysts
Phase 2
foralumab
foralumab [INN]
Alzheimer's Disease
$TLSATiziana Life Sciences Ltd
0 catalysts
Phase 2
foscenvivint
foscenvivint [INN]
Colorectal Cancer
Eisai Co Ltd
0 catalysts